Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial-Reference-Cited by-同舟云学术

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

Published:2015-11 Issue:10006 Volume:386 Page:1825-1834
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Khanna Reena,Bressler Brian,Levesque Barrett G,Zou Guangyong,Stitt Larry W,Greenberg Gordon R,Panaccione Remo,Bitton Alain,Paré Pierre,Vermeire Séverine,D'Haens Geert,MacIntosh Donald,Sandborn William J,Donner Allan,Vandervoort Margaret K,Morris Joan C,Feagan Brian G

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management;Dignass;J Crohn's Colitis,2010

2. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study;Beaugerie;Lancet,2009

3. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial;D'Haens;Lancet,2008

4. Infliximab, azathioprine, or combination therapy for Crohn's disease;Colombel;N Engl J Med,2010

5. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry;Lichtenstein;Am J Gastroenterol,2012

Cited by 373 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How comparative studies can inform treatment decisions for Crohn’s disease;Expert Opinion on Biological Therapy;2024-08-12

2. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

3. When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease;American Journal of Gastroenterology;2024-07-15

4. Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD;Alimentary Pharmacology & Therapeutics;2024-07-12

5. Effects of smoking on clinical treatment outcomes amongst patients with chronic inflammatory diseases initiating biologics: secondary analyses of the prospective BELIEVE cohort study;Scandinavian Journal of Immunology;2024-07-07